Page results
- 
                                    
                                                                            
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
 - 
                                    
                                                                            
UCLH will play a vital role in a new respiratory virus study.
 - 
                                    
                                                                            
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
 - 
                                    
                                                                            
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
 - 
                                    
                                                                            
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
 - 
                                    
                                                                            
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
 - 
                                    
                                                                            
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
 - 
                                    
                                                                            
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
 - 
                                    
                                                                            
As a mark of respect for the funeral of Her Majesty The Queen on Monday 19 September, we are postponing our Annual Members’ Meeting, which was scheduled for this date.
 - 
                                    
                                                                            
A tribute to Her Majesty The Queen
 
File results
- 
                                                                            
FOI/2023/0437 - Outsourced and insourced procedures for dermatology, endoscopy and gynaecology procedures from 2017/18-2022/23
 - 
                                                                            
FOI/2023/0438 - Outsourced and insourced procedures dermatology, endoscopy and gynaecological procedures
 - 
                                                                            
FOI/2023/0446 - Senior staff contact details
 - 
                                                                            
FOI/2023/0447 - Excessive exposure to Nitrous Oxide via Entonox from 2018-2023
 - 
                                                                            
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
 - 
                                                                            
Neuroimmunology and CSF Laboratory User Handbook
 - 
                                                                            
FOI/2023/0236 - Proton Beam Therapy Centre
 - 
                                                                            
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
 - 
                                                                            
FOI/2023/0462 - Patients to hotels
 - 
                                                                            
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023